Advertisement

Dunlop's

Main information

  • Trade name:
  • Dunlop's 20% w/v PMD Solution for Injection
  • Pharmaceutical form:
  • Solution for injection
  • Prescription type:
  • POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
Advertisement

Documents

Localization

  • Available in:
  • Dunlop's 20% w/v PMD Solution for Injection
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • Sheep
  • Therapeutic area:
  • Mineral

Other information

Status

  • Source:
  • VMD - Veterinary Medicines Directorate
  • Authorization status:
  • Authorized
  • Authorization number:
  • 02000/4206
  • Authorization date:
  • 23-05-2000
  • Last update:
  • 21-12-2016

Summary of Product characteristics

Revised: July 2010

ATCVet code amended

SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Dunlops 20% w/v PMD Solution for Injection

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active Substance:

Contains Calcium Gluconate  16.6% w/v

Magnesium Hypophosphite Hexahydrate  5% w/v

Glucose Monohydrate  22.0% w/v 

Each 400 ml contains:

5.92 g calcium (provided by calcium gluconate and calcium 

borogluconate)

1.84 g magnesium (provided by magnesium hypophosphite 

hexahydrate)

80 g glucose provided by glucose monohydrate.

Also contains 3.40% w/v boric aid.

Excipients:

Chlorocresol  0.1% w/v

For a full list of excipients, see section 6.1

3. PHARMACEUTICAL FORM

Solution for injection

A clear, pale yellow aqueous solution

4. CLINICAL PARTICULARS

4.1 Target species

Sheep

4.2 Indications for use, specifying the target species

For the treatment of hypocalcaemia complicated by deficiency of 

magnesium with accompanying hypoglycaemia.  In the treatment of 

pregnancy toxaemia and other metabolic imbalances in periparturient 

sheep

Revised: July 2010

ATCVet code amended

4.3 Contraindications

Not to be administered by intravenous or intramuscular routes

4.4 Special Warnings for each target species

No special warning.

4.5 Special precautions for use

Special precautions for use in animals

The solution should be warmed to body temperature before 

administration.

Special precautions to be taken by the person administering the 

veterinary medicinal product to animals

Care should be taken to avoid accidental self-injection.  

If accidental self-injection occurs, seek medical advice. Wash 

hands after use.

4.6 Adverse reactions (frequency and seriousness)

None

4.7 Use during pregnancy, lactation or lay

Can be safely administered to pregnant and lactating animals

4.8 Interaction with other medicinal products and other forms of 

interaction

None known

4.9 Amounts to be administered and administration route

The solution should be warmed to body temperature before 

administration by subcutaneous injection only.  Observe aseptic 

precautions.  Sites of administration should be massaged gently.

Sheep: 50 - 80 ml

4.10 Overdose (symptoms, emergency procedures, antidotes), if 

necessary

Not applicable.

Revised: July 2010

ATCVet code amended

4.11 Withdrawal period

Meat – Zero days 

Milk – Zero hours

5. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group:  Mineral supplements, Calcium, 

Calcium, combinations with other drugs

ATC Vet Code:  QA12AX

5.1 Pharmacodynamic properties

Milk fever, characterised by hypocalcaemia is caused by an acute drop 

in the level of calcium in the blood.  At parturition hypophosphataemia 

and hypomagnesaemia can also occur.  When administered by 

subcutaneous injection the product replenishes plasma concentrations 

of calcium, phosphate and magnesium ions.  Dextrose is included as 

an energy source to coincide with the high turnover of energy during 

lambing.

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Chlorocresol

Sodium Bicarbonate (for pH adjustment)

Water for Injection

6.2 Incompatibilities

None known

6.3 Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 

Amber Glass Bottles 2 years.

Polypropylene Vials 2 years.

Shelf life after first opening the immediate packaging: 28 days

6.4 Special precautions for storage

Following withdrawal of the first dose use the contents within 28 

days. Discard unused material.

Do not store above 25°C.

Protect from light.

Revised: July 2010

ATCVet code amended

6.5 Nature and composition of immediate packaging

400 ml amber Type III glass bottles, with natural rubber wads and 

aluminium screw caps or 400 ml polypropylene vials with bromobutyl 

bungs and aluminium overseals

6.6 Special precautions for the disposal of unused veterinary medicinal 

product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived 

from such veterinary medicinal products should be disposed of in 

accordance with local requirements.

7. MARKETING AUTHORISATION HOLDER

Norbrook Laboratories Limited

Station Works

Newry

Co. Down, BT35 6JP

8. MARKETING AUTHORISATION NUMBER(S)

Vm

 02000/4206

9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE 

AUTHORISATION

Date of first authorisation: 23 rd  May 2000

10. DATE OF REVISION OF THE TEXT

July 2010

11-12-2017

FDA Drug Safety Communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections

FDA Drug Safety Communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections

A U.S. Food and Drug Administration (FDA) safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors about the risks of too much acid in the blood and of serious urinary tract infections. Both conditions can result in hospitalization.

FDA - U.S. Food and Drug Administration

20-10-2017

Spirit Halloween recalls Spirit Mini Slime

Spirit Halloween recalls Spirit Mini Slime

The product presents a risk to children because it contains boric acid. Boric acid can be toxic to children if licked or swallowed. Children are more sensitive to boric acid toxicity than adults. High levels of boric acid ingestion may have long-term effects on a child's development and their future reproductive health.

Health Canada

20-10-2017

Spirit Halloween recalls Spirit Flarp Noise Putty

Spirit Halloween recalls Spirit Flarp Noise Putty

The product presents a risk to children because it contains boric acid. Boric acid can be toxic to children if licked or swallowed. Children are more sensitive to boric acid toxicity than adults. High levels of boric acid ingestion may have long-term effects on a child's development and their future reproductive health.

Health Canada

2-1-2018

SEE CLEAN-ONE EYE DROPS (Boric Acid) Liquid [Cho-A Pharm.Co.,Ltd.]

SEE CLEAN-ONE EYE DROPS (Boric Acid) Liquid [Cho-A Pharm.Co.,Ltd.]

Updated Date: Jan 2, 2018 EST

US - DailyMed

19-12-2017

ANTACID SUPREME (Calcium Carbonate, Magnesium Hydroxide) Suspension [FREDS, INC]

ANTACID SUPREME (Calcium Carbonate, Magnesium Hydroxide) Suspension [FREDS, INC]

Updated Date: Dec 19, 2017 EST

US - DailyMed

13-11-2017

Prevacid vs. Nexium

Prevacid vs. Nexium

Prevacid (lansoprazole) and Nexium (esomeprazole magnesium) are proton pump inhibitors (PPIs) used to treat and prevent stomach and intestinal ulcers, gastroesophageal reflux disease (GERD), erosive esophagitis (damage to the esophagus from stomach acid), and other conditions involving excessive stomach acid such as Zollinger-Ellison syndrome. Both Prevacid and Nexium are available over-the-counter (OTC) and in generic form.

US - RxList

2-11-2017

Calcium Gluconate

Calcium Gluconate

Calcium gluconate is the calcium salt of gluconic acid, an intravenous medication used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyrodism, and hypocalcemia due to rapid growth or pregnancy.

US - RxList

Advertisement